February 20, 2025
February 20, 2025
Youth Pulmonary Embolism Trends Identified
February 20, 2025
Depressive Symptoms Surge Among U.S. High School Students
February 20, 2025
Smoking Cessation Intervention Effective in Opioid Users
February 20, 2025
Study Confirms Accuracy of Self-Collection for HPV Screening
Latest Headlines
View More
February 21, 2025
Epidural Steroids Offer Short-Term, Not Long-Term Relief
February 21, 2025
Filgotinib Shows Long-Term Safety in RA Patients
February 20, 2025
Medical Oddities: Sugar Sensors in the Heart?
February 20, 2025
Is GLP-1RA Use Tied to Short-Term Thyroid Cancer Risk?
February 20, 2025
Youth Pulmonary Embolism Trends Identified
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Conference Coverage
American Stroke Association International Stroke Conference 2025
February 19, 2025
Late-Window Alteplase in Acute Ischemic Stroke
February 18, 2025
Telomere Length May Signal Brain Disease Risk
February 18, 2025
New Study Shows Promise in Enhanced Stroke Treatment Protocol
AAAAI/WAO Joint Congress
February 12, 2025
Fluoroquinolones vs Amoxicillin: Anaphylaxis Risk
World Congress of Nephrology
February 12, 2025
Obinutuzumab Boosts Lupus Nephritis Treatment Success
Clinical Guidelines
View More
February 18, 2025
AAP Guide Targets Early Biliary Atresia
February 06, 2025
ASE Updates Vascular Access Ultrasound Guidelines
February 05, 2025
First Guidelines Define Standards for Closed-Loop Pain Control
February 01, 2025
Standing for Those With Intellectual/ Developmental Disabilities
Commentary & Perspectives
View More
February 18, 2025
New Study Shows Promise in Enhanced Stroke Treatment Protocol
February 12, 2025
Free Clinic, Small Town—Worth the Move?
February 12, 2025
Free Clinic, Small Town—Worth the Move?
January 30, 2025
RFK Jr.’s Vocal Cord Surgery Unapproved in U.S.
FDA & Government News
View More
February 20, 2025
NY Sues Major Vape Distributors Over Youth Marketing
February 19, 2025
FDA Approves Amneal’s Lenalidomide; Mesalamine 800 mg Launched
February 19, 2025
FDA Clears Novel Atopic Dermatitis Drug
February 18, 2025
FDA Clears Aptima SARS-CoV-2 Assay for High-Throughput Testing
Business Management
View More
February 14, 2025
